$ABEO
ABEONA THERAPEUTICS INC.

2017 Q2 Form 10-Q Financial Statement

#000114420417059034 Filed on November 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q3
Revenue $217.0K $186.0K $184.0K
YoY Change 1.4% -22.5% -36.55%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.640M $3.020M $2.390M
YoY Change -29.22% -30.89% -49.36%
% of Gross Profit
Research & Development $5.808M $2.198M $2.745M
YoY Change 92.45% 18.17% 73.73%
% of Gross Profit
Depreciation & Amortization $207.0K $250.0K $222.0K
YoY Change 14.36% 47.06% 48.0%
% of Gross Profit
Operating Expenses $5.808M $2.198M $2.745M
YoY Change 92.45% -65.66% -57.44%
Operating Profit -$8.440M -$5.284M -$5.174M
YoY Change 25.69%
Interest Expense $160.0K $40.00K $2.550M
YoY Change 1500.0% -93.55% 2733.33%
% of Operating Profit
Other Income/Expense, Net $161.0K $37.00K $2.550M
YoY Change 1241.67%
Pretax Income -$8.280M -$5.250M -$2.620M
YoY Change 23.58% -5.23% -56.84%
Income Tax
% Of Pretax Income
Net Earnings -$8.279M -$5.247M -$2.620M
YoY Change 23.51% -5.29% -56.84%
Net Earnings / Revenue -3815.21% -2820.97% -1423.91%
Basic Earnings Per Share
Diluted Earnings Per Share -$205.6K -$130.4K -$78.75K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.30M $63.20M $31.20M
YoY Change 69.97% 68.98% -27.94%
Cash & Equivalents $58.30M $63.21M $31.19M
Short-Term Investments
Other Short-Term Assets $900.0K $500.0K $200.0K
YoY Change 350.0% 150.0% 100.0%
Inventory
Prepaid Expenses
Receivables $100.0K $100.0K $600.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $59.30M $63.80M $31.90M
YoY Change 71.39% 68.78% -27.0%
LONG-TERM ASSETS
Property, Plant & Equipment $700.0K $700.0K $700.0K
YoY Change 16.67% 40.0% 600.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $37.36M $41.50M $41.90M
YoY Change -5.66% 4.8% -8.52%
TOTAL ASSETS
Total Short-Term Assets $59.30M $63.80M $31.90M
Total Long-Term Assets $37.36M $41.50M $41.90M
Total Assets $96.66M $105.3M $73.80M
YoY Change 30.27% 36.05% -17.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.617M $1.500M $1.900M
YoY Change 72.24% 50.0% 90.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.219M $6.100M $6.500M
YoY Change -51.51% -19.74% 306.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.400M $3.500M $3.800M
YoY Change -15.0% -14.63% -74.5%
Total Long-Term Liabilities $3.400M $3.500M $3.800M
YoY Change -15.0% -14.63% -74.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.219M $6.100M $6.500M
Total Long-Term Liabilities $3.400M $3.500M $3.800M
Total Liabilities $7.581M $9.600M $10.30M
YoY Change -40.31% -18.64% -37.58%
SHAREHOLDERS EQUITY
Retained Earnings -$346.0M
YoY Change
Common Stock $435.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $89.08M $95.71M $63.50M
YoY Change
Total Liabilities & Shareholders Equity $96.66M $105.3M $73.80M
YoY Change 30.27% 36.05% -17.54%

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q3
OPERATING ACTIVITIES
Net Income -$8.279M -$5.247M -$2.620M
YoY Change 23.51% -5.29% -56.84%
Depreciation, Depletion And Amortization $207.0K $250.0K $222.0K
YoY Change 14.36% 47.06% 48.0%
Cash From Operating Activities -$4.980M -$5.857M -$3.990M
YoY Change 60.13% 132.42% 58.33%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $74.00K -$150.0K
YoY Change -91.67% -132.17% 400.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$10.00K -$74.00K -$150.0K
YoY Change -91.67% -67.83% -104.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 90.00K $1.000K 1.020M
YoY Change -40.0% -91.29%
NET CHANGE
Cash From Operating Activities -4.980M -$5.857M -3.990M
Cash From Investing Activities -10.00K -$74.00K -150.0K
Cash From Financing Activities 90.00K $1.000K 1.020M
Net Change In Cash -4.900M -$5.930M -3.120M
YoY Change 59.09% 115.64% -124.26%
FREE CASH FLOW
Cash From Operating Activities -$4.980M -$5.857M -$3.990M
Capital Expenditures -$10.00K $74.00K -$150.0K
Free Cash Flow -$4.970M -$5.931M -$3.840M
YoY Change 66.22% 159.0% 54.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 abeo Payable Due Licensor Current
PayableDueLicensorCurrent
0 USD
CY2016Q4 abeo Payable Due Licensor Current
PayableDueLicensorCurrent
4000000 USD
CY2016Q3 us-gaap Licenses Revenue
LicensesRevenue
151000 USD
us-gaap Licenses Revenue
LicensesRevenue
452000 USD
CY2016Q3 us-gaap Royalty Revenue
RoyaltyRevenue
33000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
181000 USD
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
184000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
633000 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2745000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7618000 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2391000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10487000 USD
CY2016Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
222000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
577000 USD
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
5358000 USD
us-gaap Costs And Expenses
CostsAndExpenses
18682000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5174000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-18049000 USD
CY2016Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2551000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3182000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-5343000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18869000 USD
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40377890 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40301601 shares
CY2017Q3 abeo Interest And Other Expense
InterestAndOtherExpense
2000 USD
abeo Interest And Other Expense
InterestAndOtherExpense
7000 USD
CY2016Q3 abeo Interest And Other Expense
InterestAndOtherExpense
1000 USD
abeo Interest And Other Expense
InterestAndOtherExpense
4000 USD
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1492000 USD
CY2017Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1243000 USD
CY2017Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 USD
CY2017Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
84000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-5247000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-8279000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
95706000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
89078000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40138000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31185000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3527000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3894000 USD
abeo Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
979000 USD
abeo Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
3120000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-13000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
491000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1607000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-159000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
11000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1038000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-2591000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-452000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-452000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17609000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9621000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
156000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
501000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-156000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-501000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
150000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
93000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5145000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1169000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12620000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8953000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
4000000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
abeo Licensed Technology
LicensedTechnology
127000 USD
abeo Licensed Technology
LicensedTechnology
0 USD
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
448000 USD
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
146000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
291000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
346000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
346000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
346000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
346000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2592000 USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40924659 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40254457 shares
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3178000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2550000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
217000 USD
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
792000 USD
CY2017Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 USD
CY2017Q3 abeo Stock Issued During Period Value Warrants One Exercised
StockIssuedDuringPeriodValueWarrantsOneExercised
5000000 USD
CY2017Q3 abeo Stock Issued During Period Value Warrants Two Exercised
StockIssuedDuringPeriodValueWarrantsTwoExercised
52000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1019000 USD
abeo Significantnoncashtransactionvalueofsharesissued
Significantnoncashtransactionvalueofsharesissued
0 USD
abeo Significantnoncashtransactionvalueofsharesissued
Significantnoncashtransactionvalueofsharesissued
2452000 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.5in"> <div><b>(5)</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Litigation</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">We are not currently subject to any material legal proceedings.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
87000 USD
CY2016Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
6.44

Files In Submission

Name View Source Status
0001144204-17-059034-index-headers.html Edgar Link pending
0001144204-17-059034-index.html Edgar Link pending
0001144204-17-059034.txt Edgar Link pending
0001144204-17-059034-xbrl.zip Edgar Link pending
abeo-20170930.xml Edgar Link completed
abeo-20170930.xsd Edgar Link pending
abeo-20170930_cal.xml Edgar Link unprocessable
abeo-20170930_def.xml Edgar Link unprocessable
abeo-20170930_lab.xml Edgar Link unprocessable
abeo-20170930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv478731_10q.htm Edgar Link pending
tv478731_ex31-1.htm Edgar Link pending
tv478731_ex31-2.htm Edgar Link pending
tv478731_ex32-1.htm Edgar Link pending
tv478731_ex32-2.htm Edgar Link pending